S. Alaçam Et Al. , "Evaluation of drug resistance mutations in patients with chronic hepatitis B," FOLIA MICROBIOLOGICA , vol.64, no.2, pp.237-243, 2019
Alaçam, S. Et Al. 2019. Evaluation of drug resistance mutations in patients with chronic hepatitis B. FOLIA MICROBIOLOGICA , vol.64, no.2 , 237-243.
Alaçam, S., Karabulut, N., Yolcu, A., Onel, M., Atasoy, A., Kaymakoglu, S., ... Agacfidan, A.(2019). Evaluation of drug resistance mutations in patients with chronic hepatitis B. FOLIA MICROBIOLOGICA , vol.64, no.2, 237-243.
Alaçam, Sema Et Al. "Evaluation of drug resistance mutations in patients with chronic hepatitis B," FOLIA MICROBIOLOGICA , vol.64, no.2, 237-243, 2019
Alaçam, Sema Et Al. "Evaluation of drug resistance mutations in patients with chronic hepatitis B." FOLIA MICROBIOLOGICA , vol.64, no.2, pp.237-243, 2019
Alaçam, S. Et Al. (2019) . "Evaluation of drug resistance mutations in patients with chronic hepatitis B." FOLIA MICROBIOLOGICA , vol.64, no.2, pp.237-243.
@article{article, author={Sema Alaçam Et Al. }, title={Evaluation of drug resistance mutations in patients with chronic hepatitis B}, journal={FOLIA MICROBIOLOGICA}, year=2019, pages={237-243} }